You are viewing an incomplete version of our website. Please click to reload the website as full version.

Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1) antibody (PE)

Details for Product No. ABIN118627, Supplier: Login to see New
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms ENTPD1, MGC80631, zgc:100819, entpd1, MGC79567, ATPDase, CD39, NTPDase-1, 2610206B08Rik, AA408691, Cd39
(100), (59), (15)
(73), (38), (35), (6), (2)
Clonality (Clone)
Monoclonal ()
(26), (18), (7), (6), (5), (3), (2), (2), (2), (1), (1), (1), (1)
Flow Cytometry (FACS)
(87), (62), (25), (22), (20), (9), (8), (4), (3), (2), (2), (2), (2), (2), (2), (1), (1)
Pubmed 4 references available
Supplier Login to see New
Catalog number from supplier Login to see New
Quantity 100 tests
Shipping to United States ( )
Availability Will be delivered in 6 to 8 Business Days
Immunogen PHA activated human lymphocytes
Clone A1
Isotype IgG1
Specificity This antibody binds to the Human CD39 cell surface antigen, a 70-100 kDa molecule expressed on peripheral blood B cells, monocytes and T cell clones. CD39 has intrinsic ecto-ATPase activity. Expression is induced on T cells and increased on B cells as a late activation antigen. This antibody has been shown to block MHC independent target cell recognition by hapten-specific CTL. SM1101A is recommended for this purpose (Ref.8).
Purification Affinity Chromatography on Protein G.
Alternative Name CD39 / ENTPD1 (ENTPD1 Antibody Abstract)
Background Human CD39 is found on most mature B cells, activated NK cells and activated T cells. CD39 is also weakly expressed on granulocytes. CD39 has homology to the Nmyc family of proteins and was recently cloned. CD39 can hydrolyze both nucleoside triphosphates and diphosphates. CD39 is the dominant ecto nucleotidase of vascular and placental trophoblastic tissues and appears to modulate the functional expression of type 2 purinergic (P2) G protein coupled receptors (GPCRs). CD39 transgenic mice exhibit impaired platelet aggregation, prolonged bleeding times, and resistance to systemic thromboembolism. There is a correlation between ATP hydrolysis and triglycerides in patients with chronic heart disease, suggesting a relationship between ATP diphosphohydrolase and thrombogenesis. Depolarization causes the endothelial production of superoxide, which inhibits the activity of endothelial CD39 and enhances platelet aggregation. After exercise, all subjects showed a significant reduction of CD39 expression in platelet and an increase of CD39 expression in B lymphocytes.Synonyms: ATPDase, Ecto-ATP diphosphohydrolase, Ecto-apyrase, Ectonucleoside triphosphate diphosphohydrolase 1, Lymphoid cell activation antigen, NTPDase 1
Gene ID 953
NCBI Accession NP_001091645
UniProt P49961
Research Area CD Antigens, Surface Receptors of Immune Cells
Application Notes Flow Cytometry: Use 10 μL of neat antibody to label 10^6 cells in 100 μL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. Further Comments: This antibody has been shown to block MHC independent target cell recognition by hapten- specific CTL. ABIN118624 is recommended for this purpose (8).
Restrictions For Research Use only
Reconstitution Restore with 1.0 mL distilled water.
Concentration 0.1 mg/mL
Buffer PBS, pH 7.4 containing 0.09 % Sodium Azide as preservative and 1 % BSA as stabilizer.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice This product is photosensitive and should be protected from light
Storage 4 °C
Storage Comment Prior to and following reconstitution store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
Background publications Stöckl, Majdic, Fischer et al.: "Monomorphic molecules function as additional recognition structures on haptenated target cells for HLA-A1-restricted, hapten-specific CTL." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 167, Issue 5, pp. 2724-33, 2001 (PubMed).

Aversa, Suranyi, Waugh et al.: "Detection of a late lymphocyte activation marker by A1, a new monoclonal antibody." in: Transplantation proceedings, Vol. 20, Issue 1, pp. 49-52, 1988 (PubMed).

Aversa, Waugh, Bishop et al.: "Use of monoclonal antibodies to study in vivo and in vitro-activated lymphocytes." in: Transplantation proceedings, Vol. 21, Issue 1 Pt 1, pp. 349-50, 1989 (PubMed).

Suranyi, Bishop, Clayberger et al.: "Lymphocyte adhesion molecules in T cell-mediated lysis of human kidney cells." in: Kidney international, Vol. 39, Issue 2, pp. 312-9, 1991 (PubMed).

Catalog No. ABIN118627
Plus shipping costs $45.00

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)